Michael A. den Bakker

8.2k citations

109 papers · 3.2k indexed · h-index 35

Oncology top 2%
- Lung Cancer Research Studies 14
- Vascular Tumors and Angiosarcomas 9
Rheumatology top 2%
- Soft tissue tumor case studies 8
Neurology top 2%
- Neurofibromatosis and Schwannoma Cases 11
- Neuroblastoma Research and Treatments 9
- Myasthenia Gravis and Thymoma 7
Gastroenterology top 2%
Pulmonary and Respiratory Medicine top 2%
- Sarcoma Diagnosis and Treatment 15
Epidemiology
- Neuroendocrine Tumor Research Advances 13

Co-authors: Cornelis Verhoef John A. Foekens Stefan Sleijfer Winand N.M. Dinjens Alexander Marx Hans Gelderblom Jeroen S. Kloover Danique L. M. van Broekhoven
Cited by: Oncology Rheumatology Neurology
Journals: Journal of Clinical Oncology (1 paper)Radiology (1 paper)Clinical Cancer Research (2 papers)
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Michael A. den Bakker

106 papers receiving 3.2k citations

Peers

Countries citing papers authored by Michael A. den Bakker

Since Specialization

Citations

This map shows the geographic impact of Michael A. den Bakker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. den Bakker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. den Bakker more than expected).

Fields of papers citing papers by Michael A. den Bakker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. den Bakker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. den Bakker. The network helps show where Michael A. den Bakker may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Michael A. den Bakker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael A. den Bakker Line = papers co-authored together Michael A. den Bakker links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	OTP, CD44, and Ki-67: A Prognostic Marker Panel for Relapse-Free Survival in Patients with Surgically Resected Pulmonary Carcinoid Modern Pathology ·Laura Moonen,Jules L. Derks,Michael A. den Bakker,Lisa M. Hillen,Robert Jan van Suylen,Jan H. von der Thüsen,L. Lap,Britney J. C. A. Marijnissen,Ronald Damhuis,Kim M. Smits,Esther C. van den Broek,Wieneke A. Buikhuisen,Anne‐Marie C. Dingemans,Ernst‐Jan M. Speel	2024	3
2	Identification of Defined Molecular Subgroups on the Basis of Immunohistochemical Analyses and Potential Therapeutic Vulnerabilities of Pulmonary Carcinoids Journal of Thoracic Oncology ·D J G Leunissen,Laura Moonen,Jan H. von der Thüsen,Michael A. den Bakker,Lisa M. Hillen,T J J van Weert,Axel zur Hausen,Thierry van den Bosch,L. Lap,Ronald Damhuis,Niki L. Reynaert,Esther C. van den Broek,Lynnette Fernandez‐Cuesta,M. Foll,N. Alcala,A. Sexton Oates,Anne‐Marie C. Dingemans,E.J.M. Speel,Jules L. Derks	2024	6
3	Neurogenic tumours of the posterior mediastinum and differential diagnosis considerations Histopathology ·Michael A. den Bakker,Annikka Weissferdt	2023	1
4	Biopsy prostate cancer perineural invasion and tumour load are associated with positive posterolateral margins at radical prostatectomy: implications for planning of nerve‐sparing surgery Histopathology ·Margaretha A. van der Slot,Sebastiaan Remmers,Charlotte F. Kweldam,Michael A. den Bakker,Daan Nieboer,Martijn B. Busstra,M. Gan,Sjoerd Klaver,John Rietbergen,Geert J.L.H. van Leenders,(unknown)	2023	4
5	Functional Ex Vivo Tissue-Based Chemotherapy Sensitivity Testing for Breast Cancer Cancers ·Marjolijn M. Ladan,Titia G. Meijer,Nicole S. Verkaik,Zofia M. Komar,Carolien H. M. van Deurzen,Michael A. den Bakker,Roland Kanaar,Dik C. van Gent,Agnes Jager	2022	5
6	Partial versus complete prostatectomy specimen sampling: prospective non-inferiority study for pT3a tumours and surgical margin involvement BMJ Open ·E.R.P. Collette,Michael A. den Bakker,Sjoerd Klaver,André N. Vis,Mike Kliffen	2019	4
7	Functional Ex Vivo Assay Reveals Homologous Recombination Deficiency in Breast Cancer Beyond BRCA Gene Defects Clinical Cancer Research ·Titia G. Meijer,Nicole S. Verkaik,Anieta M. Sieuwerts,Job van Riet,Kishan A.T. Naipal,Carolien H. M. van Deurzen,Michael A. den Bakker,Hein F.B.M. Sleddens,Hendrikus-Jan Dubbink,T. Dorine den Toom,Winand N.M. Dinjens,Esther H. Lips,Petra M. Nederlof,Marcel Smid,Harmen J.G. van de Werken,Roland Kanaar,John W.M. Martens,Agnes Jager,Dik C. van Gent	2018	47
8	Conventional Autopsy versus Minimally Invasive Autopsy with Postmortem MRI, CT, and CT-guided Biopsy: Comparison of Diagnostic Performance Radiology ·Britt M. Blokker,Annick C. Weustink,Ivo M. Wagensveld,Jan H. von der Thüsen,Andrea Pezzato,Rúben Dammers,Jan Bakker,Nomdo S. Renken,Michael A. den Bakker,Folkert J. van Kemenade,Gabriël P. Krestin,M. G. Myriam Hunink,J. Wolter Oosterhuis	2018	38
9	The prevalence of CD146 expression in breast cancer subtypes and its relation to outcome Annals of Oncology ·I.E. de Kruijff,Anne Timmermans,Michael A. den Bakker,Anita M.A.C. Trapman,Renée Foekens,Esther Oomen‐de Hoop,Marcel Smid,Antoinette Hollestelle,Carolien H. M. van Deurzen,M.E. Meijer - van Gelder,John A. Foekens,John W.M. Martens,Stefan Sleijfer,A Tjon	2017	2
10	Time Trends in the Incidence and Treatment of Extra-Abdominal and Abdominal Aggressive Fibromatosis: A Population-Based Study Annals of Surgical Oncology ·Danique L. M. van Broekhoven,Dirk J. Grünhagen,Michael A. den Bakker,Thijs van Dalen,Cornelis Verhoef	2015	77
11	Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer Breast Cancer Research and Treatment ·Antoinette Hollestelle,Justine Peeters,Marcel Smid,Mieke Timmermans,Leon C. Verhoog,Pieter J. Westenend,Anouk A. J. Heine,Alan Chan,Anieta M. Sieuwerts,Erik A.C. Wiemer,Jan G.M. Klijn,Peter J. van der Spek,John A. Foekens,Mieke Schutte,Michael A. den Bakker,John W.M. Martens	2013	103
12	A new approach for rapid and reliable enumeration of circulating endothelial cells in patients Journal of Thrombosis and Haemostasis ·Jaco Kraan,Michiel Strijbos,Anieta M. Sieuwerts,John A. Foekens,Michael A. den Bakker,Cornelis Verhoef,Stefan Sleijfer,Jan W. Gratama	2012	49
13	Solitary, multifocal and generalized myofibromas: clinicopathological and immunohistochemical features of 114 cases Histopathology ·Lindsey Oudijk,Michael A. den Bakker,Wim C.J. Hop,Marta C. Cohen,Adrian Charles,Rita Alaggio,Cheryl M. Coffin,Ronald R. de Krijger	2012	47
14	Protease-Activated Receptor-2 Induces Myofibroblast Differentiation and Tissue Factor Up-Regulation during Bleomycin-Induced Lung Injury American Journal Of Pathology ·Keren Borensztajn,Paul Bresser,Chris van der Loos,Ilze Bot,Bernt van den Blink,Michael A. den Bakker,Joost Daalhuisen,A.P. de Groot,Maikel P. Peppelenbosch,Jan H. von der Thüsen,C. Arnold Spek	2010	49
15	Combined therapy for thyroid squamous cell carcinoma Head & Neck ·Filip De Vos,Aniel Sewnaik,Johannes H. W. de Wilt,Ernst J. Smid,Michael A. den Bakker,Esther van Meerten	2010	8
16	TP53Mutation Analysis of Malignant Peripheral Nerve Sheath Tumors Journal of Neuropathology & Experimental Neurology ·Robert M. Verdijk,Michael A. den Bakker,Hendrikus J. Dubbink,Wim C.J. Hop,Winand N.M. Dinjens,Johan M. Kros	2009	42
17	Gene Expression Profiles Associated with the Presence of a Fibrotic Focus and the Growth Pattern in Lymph Node–Negative Breast Cancer Clinical Cancer Research ·Gert G. Van den Eynden,Marcel Smid,Steven Van Laere,Cécile Colpaert,Ilse Van der Auwera,Trinh Xuan Bich,Peter A. van Dam,Michael A. den Bakker,Luc Dirix,Eric A. Van Marck,Peter Vermeulen,John A. Foekens	2008	23
18	Nitrofurantoin-induced pulmonary fibrosis: a case report Journal of Medical Case Reports ·Natascha Goemaere,Karin Grijm,Peter Th. W. van Hal,Michael A. den Bakker	2008	41
19	Cells meeting our immunophenotypic criteria of endothelial cells are large platelets Cytometry Part B Clinical Cytometry ·Michiel Strijbos,Jaco Kraan,Michael A. den Bakker,Bart N. Lambrecht,Stefan Sleijfer,Jan W. Gratama	2007	55
20	Malignant mesenchymoma of the uterus, arising in a leiomyoma Histopathology ·Michael A. den Bakker,Vincent Noordhoek Hegt,H B F M Sleddens,A S M Nuijten,Winand N.M. Dinjens	2002	14

About Michael A. den Bakker

Michael A. den Bakker is a scholar working on Neurology, Rheumatology and Oncology, having authored 109 papers that have together received 3.2k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (15 papers), Lung Cancer Research Studies (14 papers), Neuroendocrine Tumor Research Advances (13 papers), Neurofibromatosis and Schwannoma Cases (11 papers), Neuroblastoma Research and Treatments (9 papers), Vascular Tumors and Angiosarcomas (9 papers), Soft tissue tumor case studies (8 papers) and Myasthenia Gravis and Thymoma (7 papers). The work is most often cited by research in Oncology (1.1k citations), Rheumatology (592 citations) and Neurology (595 citations). Michael A. den Bakker has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Cornelis Verhoef, John A. Foekens, Stefan Sleijfer, Winand N.M. Dinjens, Alexander Marx, Hans Gelderblom, Jeroen S. Kloover, Danique L. M. van Broekhoven, Dirk J. Grünhagen and Jan P. van Meerbeeck. Their work appears in journals such as Journal of Clinical Oncology, Radiology and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact